Lexeo Therapeutics Inc
NASDAQ:LXEO
Income Statement
Earnings Waterfall
Lexeo Therapeutics Inc
Income Statement
Lexeo Therapeutics Inc
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(33)
|
(54)
|
(69)
|
(72)
|
(82)
|
(94)
|
(106)
|
(117)
|
(123)
|
(114)
|
|
| Selling, General & Administrative |
(6)
|
(9)
|
(15)
|
(20)
|
(24)
|
(29)
|
(32)
|
(41)
|
(50)
|
(48)
|
|
| Research & Development |
(28)
|
(45)
|
(53)
|
(52)
|
(58)
|
(64)
|
0
|
(76)
|
(74)
|
(66)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(74)
|
0
|
0
|
0
|
|
| Operating Income |
(33)
N/A
|
(54)
-61%
|
(69)
-28%
|
(72)
-5%
|
(82)
-14%
|
(94)
-14%
|
(106)
-13%
|
(117)
-10%
|
(123)
-6%
|
(114)
+8%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
1
|
2
|
3
|
4
|
5
|
7
|
0
|
7
|
9
|
9
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
(0)
|
(1)
|
0
|
(1)
|
(0)
|
8
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(32)
N/A
|
(52)
-63%
|
(66)
-27%
|
(70)
-5%
|
(77)
-11%
|
(87)
-12%
|
(98)
-13%
|
(109)
-11%
|
(114)
-5%
|
(105)
+8%
|
|
| Net Income | |||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(32)
|
(52)
|
(66)
|
(70)
|
(77)
|
(87)
|
(98)
|
(109)
|
(114)
|
(105)
|
|
| Net Income (Common) |
(32)
N/A
|
(52)
-63%
|
(66)
-27%
|
(70)
-5%
|
(77)
-11%
|
(87)
-12%
|
(98)
-13%
|
(109)
-11%
|
(114)
-5%
|
(105)
+8%
|
|
| EPS (Diluted) |
-1.3
N/A
|
-2.12
-63%
|
-2.69
-27%
|
-2.49
+7%
|
-2.34
+6%
|
-2.62
-12%
|
-3.06
-17%
|
-3.3
-8%
|
-2.62
+21%
|
-1.72
+34%
|
|